Photodynamic therapy for onychomycosis. Case report and review of the literature

被引:17
作者
Aspiroz, Carmen [1 ]
Fortuno Cebamanos, Blanca [1 ]
Rezusta, Antonio [2 ]
Paz-Cristobal, Pablo
Dominguez-Luzond, Fernando [3 ]
Gene Diaz, Josepa [4 ]
Gilaberte, Yolanda [5 ]
机构
[1] Hosp Royo Villanova, Unidad Microbiol, Zaragoza, Spain
[2] Hosp Miguel Server, Serv Microbiol, Zaragoza, Spain
[3] Ctr Salud Arrabal, Zaragoza, Spain
[4] Univ Rovira & Virgili, Unitat Microbiol, Fac Med & Ciencies Salut, Tarragona, Spain
[5] Hosp San Jorge, Serv Dermatol, Huesca, Spain
来源
REVISTA IBEROAMERICANA DE MICOLOGIA | 2011年 / 28卷 / 04期
关键词
Onychomycosis; Finger nail; Photodynamic therapy; Non-dermatophytes; Molds; Acremonium; Acremonium sclerotigenum; TOENAIL ONYCHOMYCOSIS; TRICHOPHYTON-RUBRUM; TERBINAFINE; INFECTIONS; MOLDS;
D O I
10.1016/j.riam.2011.03.004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background: Onychomycosis is one of the most prevalent fungal infections in the population with a higher rate of treatment failures. Photodynamic therapy (PDT) is based on the use of photosensitizers with light of an accurate wavelength, and in the presence of oxygen, reactive oxygen species are produced which induce cell death. PDT is widely used to treat non-melanoma skin cancer, and other indications are being investigated, especially in superficial infections. Aims: To determine the effectiveness of PDT in a case of onychomycosis caused by moulds. Methods: A 75-year-old woman was diagnosed with onychomycosis caused by Acremonium sclerotigenum in the 5th finger. She was treated with 3 sessions of PDT with methyl-aminolevulinate (MAL) separated by 15 days. Results: The patient achieved mycological and clinical cure and remains asymptomatic after 12 months of follow up. Conclusions: This case illustrates the potential usefulness of MAL-PDT for onychomycosis. Its effectiveness, lack of adverse effects and satisfaction on the part of physicians and patients, suggest a promising future for this therapy in the management of superficial fungal infections, such as onychomycosis. (C) 2010 Revista Iberoamericana de Micologia. Published by Elsevier Espana, S.L. All rights reserved.
引用
收藏
页码:191 / 193
页数:3
相关论文
共 20 条
[1]   Onychomycosis Insensitive to Systemic Terbinafine and Azole Treatments Reveals Non-Dermatophyte Moulds as Infectious Agents [J].
Baudraz-Rosselet, Florence ;
Ruffieux, Catherine ;
Lurati, Massimo ;
Bontems, Olympia ;
Monod, Michel .
DERMATOLOGY, 2010, 220 (02) :164-168
[2]   A comprehensive overview of photodynamic therapy in the treatment of superficial fungal infections of the skin [J].
Calzavara-Pinton, PG ;
Venturini, M ;
Sala, R .
JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY, 2005, 78 (01) :1-6
[3]   Drug delivery strategies for photodynamic antimicrobial chemotherapy: From benchtop to clinical practice [J].
Cassidy, Corona M. ;
Tunney, Michael M. ;
McCarron, Paul A. ;
Donnelly, Ryan F. .
JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY, 2009, 95 (02) :71-80
[4]  
del Palacio A, 2001, ENFERM INFEC MICR CL, V19, P439
[5]   A full "cure" for onychomycosis is not always possible [J].
Elewski, BE .
ARCHIVES OF DERMATOLOGY, 1999, 135 (07) :852-853
[6]   How often does oral treatment of toenail onychomycosis produce a disease-free nail? An analysis of published data [J].
Epstein, E .
ARCHIVES OF DERMATOLOGY, 1998, 134 (12) :1551-1554
[7]  
GILABERTE Y, 2011, J AM ACAD D IN PRESS, P13386
[8]   PHOTODYNAMIC THERAPY IN DERMATOLOGY [J].
Gilaberte, Yolanda ;
Serra-Guillen, Carlos ;
Elena de las Heras, Ma ;
Ruiz-Rodriguez, Ricardo ;
Fernandez-Lorente, Manuel ;
Benvenuto-Andrade, Cristiane ;
Gonzalez-Rodriguez, Salvador ;
Guillen-Barona, Carlos .
ACTAS DERMO-SIFILIOGRAFICAS, 2006, 97 (02) :83-102
[9]   In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evaluation of combination antifungal activity [J].
Gupta, AK ;
Kohli, Y .
BRITISH JOURNAL OF DERMATOLOGY, 2003, 149 (02) :296-305
[10]   Literature review [J].
Hay, R .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2005, 19 :1-7